Upcoming Webinars

Overcoming Bottlenecks in PAT Deployment: Bridging the Gap Between Lab & Manufacturing

Presented by Luc Nguyen, Global Head of Process Analytical Technologies (PAT) within MSAT at Sanofi, Ramila Peiris, Global Head of Process Data Management, Machine Learning, and AI Platform MSAT at Sanofi, Maryann Cuellar, Life Science Industry Manager at Endress+Hauser Optical Analysis, Michael Sachpekidis, Global Account Director at SciY
14th October 2026

Managing Analytical Procedure Lifecycles: Resolving Longstanding Mass Spectrometry Challenges for Emerging Nitrosamine and NDSRI Impurities

Presented by Jinhui Zhang, Chemist at FDA/CDER, Andrew Teasdale, Principal Consultant at Nelson Labs
15th October 2026

Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing

Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
22nd October 2026

Navigating Particulate Matter Analysis in Biologic Drug Products: A Critical Evaluation of Flow Imaging and Light Obscuration for Product Quality Assessment

Presented by Ashwinkumar Bhirde, PhD. FDA/CDER/OPQ, Senior Research Scientist, Louise Brogan, PhD, Marketing Director, Yokogawa Fluid Imaging Technologies and Amber Raines, Ph.D., Senior Director of Client Project Management at Coriolis Pharma, U.S.
27th October 2026

Particulate Control in Parenteral Drug Delivery Devices

Presented by Rong Guo, Senior Reviewer at CDRH/FDA, Dr. Bettine Boltres, Director Scientific Affairs, Integrated Systems at West, John Rech, Technology Manager – Particle – Analytical Services at West
30th October 2026

Intelligent Biomanufacturing Systems: From Design to Control in Industry 4.0

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine, Dr. Tiago Matos, Assistant Professor Tecnico, University of Lisbon
05th November 2026

Endotoxin Testing of Pharmaceutical Products using Synthetic Reagents

Presented by Poppy Cliffe, Senior Scientist in Microbiology, Global Product Development at AstraZeneca, Nicola Reid, Director, Portfolio Product Manager, Pyrogen & Endotoxin Detection, Charles River
06th November 2026

Enhancing Plasmid DNA Quality Through Robust Topology Measurement

Presented by Dr. Anthony Blaszczyk, Principal Scientist in the Global Biologics Department at U.S. Pharmacopeia, Mateusz Imiolek, Principal Scientist at Waters
09th November 2026

Roundtable Discussion: Interpreting the New US Pharmacopoeia Guidance for Sterility & Microbial Testing in Cell Therapy

Presented by Dr. Huiping Tu, Senior Principal Scientist, Microbiology, Global Biologics United States Pharmacopeia (USP), Dr David Roesti, Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Dr. Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Dr. Lori Daane, Founder and Principal Scientist at Macro Scope BioConsulting, Dr. Ambili Menon, Senior Scientific Affairs Manager at bioMérieux
11th November 2026

Sterilization and Packaging Development: The Chicken and Egg Dilemma

Presented by Logan Luke, Senior Expert Consultant, Nelson Labs And Jean-Francois (Jeff) Zeevaert, Principal Scientist Gas Sterilization, Sterigenics
17th November 2026

Pharma Industry 4.0 Will be Advanced by the Data Enablement of People

Presented by Malcom Jeffers, Transformation Strategist, Head of Research at the International Academy of Automation Engineering, Alan Bateman, Director: Systems Architecture, Digital, and Execution at Johnson & Johnson Innovative Medicines, Dan Hill, Director, Process Analytics at Fujufilm Biotechnologies
18th November 2026

Characterization of Lipid Nanoparticles Using Macro Mass Photometry Insights into Size & Mass

Presented by Presented by Jikang Wu, Senior Principal Scientist in Analytical and Biological Mass Spectrometry at Regeneron Pharmaceuticals
19th November 2026

Aggregation Analysis in AAV: Selecting Fit-for-Purpose Assays

Presented by Margaret Butko, Ph.D., Senior Advisor of CMC Assay Development at Eli Lilly and Company, Rickard Nordström Chief Operating Officer at QuTEM
02nd December 2026

Integrating E&L Assessment and Filter Validation for Sterilizing Grade Filters used in (Bio-)Pharmaceutical Manufacturing

Presented by Presented by Lijun Song, PhD, Scientific Project Manager at Nelson Labs and Peter Cornelis, Senior expert Microbiology and Sterilization at Nelson Labs
10th December 2026

Applied Automation and Mechanistic Modeling for Purification Development of Challenging Molecules under Accelerated Timelines

Presented by Scott H. Altern, Senior Scientist II at AbbVie Bioresearch Center in Worcester, MA
11th January 2027

Navigating Assay Re-Development & Transfer to Reduce Risk & Delays in GMP Testing

Presented by Sviatlana Rose, Principal Scientist at Sanofi
15th January 2027

Innovation and Technology development strategies for successful implementation

Presented by Irina Ramos, PhD, Senior Distinguished Scientist, CMC and Innovation Lead at J&J Innovative Medicine
19th January 2027

PAT Evolution and Implementation: Navigating Regulatory Guidelines, and Best Practices for Tool Selection and Validation

Presented by Presented by Dr. Farshid Mohammadparast, Process Analytical Technology (PAT) and Chemometrics Principal Investigator at USP, Atanu Sengupta, Lead – New Technologies & External Collaborations at Dr. Reddy’s Laboratories, Parag Borgaonkar, MBA, Sr. Business Development Specialist at Thermo Fisher Scientific, Sudhir Dahal, PhD., Product Marketing Manager for Research Raman Products at Thermo Fisher Scientific
25th January 2027

Scaling Up TFF for Upstream Continuous Processing: Applications of Mechanistic Modeling

Presented by Ashna Dhingra, Bioprocess Technologies & Engineering, Senior Scientist, AstraZeneca, April Wheeler, Senior Product Manager, Microfiltration Technologies at Asahi Kasei Bioprocess
28th January 2027

Process Development to GMP Implementation of Raman Spectroscopy as a PAT Tool for the Purification of Protein Based Therapeutics

Presented by Christina Passno, Senior Staff Engineer, Preclinical Manufacturing & Process Development at Regeneron Pharmaceuticals
02nd February 2027